secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-09-01T20:30:50+00:00
Accession:  0001193125-26-378487
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed enters $450M accelerated share repurchase with Citibank
--------------------------------------------------------------

- ASR agreement with Citibank to repurchase $450M of common stock, funded by MatrixCare sale proceeds and cash.
- Payment of $450M on Sept 3, 2026; initial delivery of 80% of $450M / Sept 2 closing price.
- Final settlement expected December 2026 based on volume-weighted average price, with potential adjustments.
- Repurchase under existing 20M share authorization from Feb 2014; contemplated in FY27 guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526378487/0001193125-26-378487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526378487/d530283d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-378487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer